Dyne Therapeutics (NASDAQ:DYN) Releases Quarterly Earnings Results, Misses Expectations By $0.01 EPS

Dyne Therapeutics (NASDAQ:DYN – Get Rating) released its quarterly earnings data on Thursday. The company reported ($1.00) earnings per share for the quarter, missing the consensus estimate of ($0.99) by ($0.01), MarketWatch Earnings reports. NASDAQ:DYN traded down $0.26 during trading hours on Friday, hitting $8.74. 1,428 shares of the stock were exchanged, compared to its […]

Related Keywords

United States ,Canada ,Wildon Farwell ,Morgan Stanley ,Zacks Investment Research ,Nasdaq ,Invesco Ltd ,York Mellon Corp ,Cubist Systematic Strategies ,Dyne Therapeutics Inc ,Royal Bank ,Dyne Therapeutics ,Get Rating ,Marketwatch Earnings ,Systematic Strategies ,New York Mellon Corp ,Nasdaq Dyn ,Ladyn ,Medical ,Earnings ,